Cargando…
Screening for type II hereditary angioedema—the “poor man’s c1-inhibitor function”
BACKGROUND: Hereditary angioedema (HAE) is a rare genetic disease. Patients with type II HAE have normal or elevated C1-inhibitor (C1-INH) levels but C1-INH protein is dysfunctional. C1-INH function requires careful sample handling and technical expertise and may account for the lack of diagnosed pa...
Autores principales: | Jindal, Ankur Kumar, Chiang, Valerie, Barman, Prabal, Sil, Archan, Chawla, Sanchi, Au, Elaine Y.L., Rawat, Amit, Li, Philip H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661124/ https://www.ncbi.nlm.nih.gov/pubmed/38026504 http://dx.doi.org/10.1016/j.jacig.2023.100179 |
Ejemplares similares
-
Long-term prophylaxis for hereditary angioedema: Initial experiences with garadacimab and lanadelumab
por: Wong, Jane C.Y., et al.
Publicado: (2023) -
An update on the genetics and pathogenesis of hereditary angioedema
por: Banday, Aaqib Zaffar, et al.
Publicado: (2019) -
Autoimmune Cytopenias in Common Variable Immunodeficiency Are a Diagnostic and Therapeutic Conundrum: An Update
por: Chawla, Sanchi, et al.
Publicado: (2022) -
Management of hereditary angioedema in resource-constrained settings: A consensus statement from Indian subcontinent
por: Jindal, Ankur Kumar, et al.
Publicado: (2023) -
Hereditary Angioedema: Diagnostic Algorithm and Current Treatment Concepts
por: Jindal, Ankur Kumar, et al.
Publicado: (2021)